Learn more. Opko Health ( OPK ) - FREE Research Report Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 24,800 shares at $9.93 on Nov. 19, 2013. Following this transaction, the CEO & Chairman owned 137.1 million shares meaning that the stake was reduced by 0.02% with the 24,800 share transaction. The shares most recently traded at $10.11, up $0.18, or 1.77% since the insider transaction. The average volume for Opko Health has been 4.9 million shares per day over the past 30 days. Opko Health has a market cap of $3.9 billion and is part of the health care sector and health services industry. Shares are up 98.54% year to date as of the close of trading on Tuesday. Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.